You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 8,790,708


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,790,708
Title:Coated tablet formulations and uses thereof
Abstract: The present invention provides coated tablet formulations comprising neratinib maleate, and improved methods for making such coated tablets.
Inventor(s): Ashraf; Muhammad (Elmwood Park, NJ), Mahmud; Mainuddin (Oak Ridge, NJ), Goolcharran; Chimanlall (East Lyme, CT), Ghosh; Krishnendu (Sparkill, NY), Nagi; Arwinder Singh (Moorpark, CA)
Assignee: Wyeth LLC (New York, NY)
Application Number:13/972,764
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,790,708
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,790,708

Introduction

United States Patent 8,790,708, hereafter referred to as US Patent 8,790,708, is a patent that has been granted by the United States Patent and Trademark Office (USPTO). To analyze the scope and claims of this patent, it is essential to delve into the details of the patent document, the broader patent landscape, and the tools and resources available for patent analysis.

Patent Details

Patent Number and Title

US Patent 8,790,708 is identified by its unique patent number and title. The title of the patent provides a brief overview of the invention or innovation it covers.

Inventors and Assignees

The patent document lists the inventors and the assignees of the patent. This information is crucial for understanding the ownership and the potential licensing or transfer of the patent rights[4].

Filing and Grant Dates

The filing date and the grant date are important milestones in the patent process. These dates help in determining the priority of the invention and the term of the patent protection[1].

Claims

The claims section of the patent is the most critical part as it defines the scope of the invention. Claims are statements that describe the invention in a way that distinguishes it from prior art. There are typically independent claims and dependent claims, with the latter building upon the former[3].

Analyzing the Claims

Independent Claims

Independent claims stand alone and define the invention without reference to other claims. These claims are broad and encompass the core aspects of the invention.

Dependent Claims

Dependent claims refer back to one or more of the independent claims and further limit the scope of the invention. They often add specific details or features to the independent claims.

Claim Construction

Claim construction is the process of interpreting the meaning of the claims. This is a critical step in determining the scope of the patent and is often a point of contention in patent litigation. The USPTO and courts use various tools and methodologies to construct the claims, including the patent specification, drawings, and the prosecution history[4].

Patent Landscape

Prior Art

Understanding the prior art is essential in assessing the novelty and non-obviousness of the invention. Prior art includes all publicly available information that existed before the filing date of the patent. Tools like the USPTO's Patent Public Search and international databases such as the European Patent Office's esp@cenet and the World Intellectual Property Organization's PATENTSCOPE can be used to search for prior art[1].

Related Patents

Identifying related patents, often referred to as the patent family, helps in understanding the broader context of the invention. The Global Dossier service provided by the USPTO allows users to see the patent family for a specific application, including related applications filed at participating IP Offices[1].

Tools and Resources for Analysis

USPTO Resources

  • Patent Public Search: This tool provides enhanced access to prior art and is a powerful resource for searching patents.
  • Global Dossier: This service allows users to view the file histories of related applications from participating IP Offices.
  • Patent and Trademark Resource Centers (PTRCs): These centers offer local search resources and training in patent search techniques[1].

International Databases

  • European Patent Office (EPO): Provides access to European patent databases through esp@cenet.
  • Japan Patent Office (JPO): Offers machine translations of Japanese patents.
  • World Intellectual Property Organization (WIPO): Features the PATENTSCOPE search service for international patent applications[1].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset contains detailed information on claims from US patents granted between 1976 and 2014. This dataset can be used to analyze claim-level statistics and document-level statistics, providing insights into patent scope and trends[3].

Legal and Practical Considerations

Patent Litigation

Patent litigation can significantly impact the value and enforceability of a patent. Factors such as the number of defendants, the type of plaintiff, and the jurisdiction can influence the outcome of patent infringement lawsuits. The Government Accountability Office (GAO) has conducted studies on patent litigation, highlighting key factors and trends[4].

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities associated with patent litigation. The Administrative Conference of the United States (ACUS) has conducted a study on this topic, engaging with various stakeholders and legal experts[2].

Case Study: US Patent 8,790,708

To illustrate the analysis, let's consider a hypothetical example based on US Patent 8,790,708.

Claim Analysis

  • Independent Claim 1: This claim defines the broad scope of the invention, such as a method or apparatus.
  • Dependent Claims: These claims further limit the scope by adding specific features or steps.

Prior Art Search

Using tools like the USPTO's Patent Public Search and international databases, one can identify prior art that may be relevant to the claims of US Patent 8,790,708.

Related Patents

The Global Dossier service can be used to identify related patents and understand the patent family, which includes all related applications filed at participating IP Offices.

Key Takeaways

  • Claims Analysis: The claims section is crucial for understanding the scope of the patent.
  • Prior Art: Searching for prior art is essential to assess the novelty and non-obviousness of the invention.
  • Patent Landscape: Understanding related patents and the broader patent landscape helps in contextualizing the invention.
  • Legal Considerations: Patent litigation and potential reforms like a small claims patent court can impact the enforceability and value of the patent.

FAQs

  1. What is the importance of the claims section in a patent?

    • The claims section defines the scope of the invention and distinguishes it from prior art, making it the most critical part of the patent document.
  2. How can I search for prior art related to a patent?

    • You can use tools like the USPTO's Patent Public Search, European Patent Office's esp@cenet, and the World Intellectual Property Organization's PATENTSCOPE.
  3. What is the Global Dossier service?

    • The Global Dossier service allows users to view the file histories of related applications from participating IP Offices, providing access to the patent family for a specific application.
  4. Why is claim construction important?

    • Claim construction is important because it determines the scope of the patent and is often a point of contention in patent litigation.
  5. What are the potential benefits of a small claims patent court?

    • A small claims patent court could address the high costs and complexities associated with patent litigation, making it more accessible for smaller entities to enforce their patent rights.

Sources

  1. USPTO - Search for patents[1]
  2. ACUS - U.S. Patent Small Claims Court[2]
  3. USPTO - Patent Claims Research Dataset[3]
  4. GAO - Assessing Factors That Affect Patent Infringement Litigation[4]

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,790,708

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Puma Biotech NERLYNX neratinib maleate TABLET;ORAL 208051-001 Jul 17, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y EXTENDED ADJUVANT TREATMENT OF ADULT PATIENTS WITH EARLY STAGE HER2-OVEREXPRESSED/AMPLIFIED BREAST CANCER, TO FOLLOW ADJUVANT TRASTUZUMAB BASE THERAPY ⤷  Subscribe
Puma Biotech NERLYNX neratinib maleate TABLET;ORAL 208051-001 Jul 17, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y EXTENDED ADJUVANT TREATMENT OF ADULT PATIENTS WITH EARLY-STAGE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2)-POSITIVE BREAST CANCER, TO FOLLOW ADJUVANT TRASTUZUMAB BASED THERAPY ⤷  Subscribe
Puma Biotech NERLYNX neratinib maleate TABLET;ORAL 208051-001 Jul 17, 2017 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y USE IN COMBINATION WITH CAPECITABINE, FOR THE TREATMENT OF ADULT PATIENTS WITH ADVANCED OR METASTATIC HER2-POSITIVE BREAST CANCER WHO HAVE RECEIVED TWO OR MORE PRIOR ANTI-HER2 BASED REGIMENS IN THE METASTATIC SETTING ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,790,708

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 078952 ⤷  Subscribe
Argentina 114143 ⤷  Subscribe
Australia 2010316683 ⤷  Subscribe
Canada 2780428 ⤷  Subscribe
China 102724970 ⤷  Subscribe
China 103893140 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.